Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Plos One|November 20, 2009
Acadesine kills chronic myelogenous leukemia (CML) cells through PKC-dependent induction of autophagic cell deathGuillaume Robert, Issam Ben Sahra, Alexandre Puissant, et al.
Molecular Cancer Therapeutics|July 2, 2009
Gene expression profiling of imatinib and PD166326-resistant CML cell lines identifies Fyn as a gene associated with resistance to BCR-ABL inhibitorsSébastien Grosso, Alexandre Puissant, Maeva Dufies, et al.
Cell Cycle (Georgetown, Tex.)|November 22, 2011
Mechanism of action of the multikinase inhibitor ForetinibMaeva Dufies, Arnaud Jacquel, Guillaume Robert, et al.
Plos One|February 13, 2009
Dual role of Sp3 transcription factor as an inducer of apoptosis and a marker of tumour aggressivenessKhadija Essafi-Benkhadir, Sébastien Grosso, Alexandre Puissant, et al.
Oncotarget|August 29, 2015
Increased SYK activity is associated with unfavorable outcome among patients with acute myeloid leukemiaKatalin Boros, Alexandre Puissant, Morgan Back, et al.
Autophagy|April 14, 2012
The anti-apoptotic Bcl-B protein inhibits BECN1-dependent autophagic cell deathGuillaume Robert, Cecile Gastaldi, Alexandre Puissant, et al.
The Journal of Investigative Dermatology|January 30, 2009
In vitro and in vivo anti-melanoma effects of ciglitazoneThomas Botton, Alexandre Puissant, Philippe Bahadoran, et al.
NAR Genomics and Bioinformatics|May 27, 2024
PitViper: a software for comparative meta-analysis and annotation of functional screening dataPaul-Arthur Meslin, Lois M Kelly, Salima Benbarche, et al.
Oncotarget|May 12, 2012
BCL2L10 is a predictive factor for resistance to azacitidine in MDS and AML patientsThomas Cluzeau, Guillaume Robert, Nicolas Mounier, et al.
Oncotarget|December 15, 2012
All tyrosine kinase inhibitor-resistant chronic myelogenous cells are highly sensitive to ponatinibOphélie Cassuto, Maeva Dufies, Arnaud Jacquel, et al.
Pageof 7